Evotec is a drug discovery alliance and development partnership company focused on rapidly progressing innovative product approaches with leading pharmaceutical and biotechnology companies. We operate worldwide providing the highest quality stand alone and integrated drug discovery solutions, covering all activities from target to clinic. The Company has established a unique position by assembling top class scientific experts and integrating state of the art technologies as well as substantial experience and expertise in key therapeutic areas including neuroscience, pain, metabolic diseases as well as oncology and inflammation. lt br / gt lt br / gt Evotec has long term discovery alliances with partners including BoehringerIngelheim, CHDI, Genentech, Medimmune/AstraZeneca, Novartis and Ono Pharmaceutical. In addition, the Company has existing development partnerships and product candidates both in clinical and preclinical development. These include partnerships with Boehringer Ingelheim, MedImmune and with Andromeda Teva in the field of diabetes and with Roche in the field of Alzheimer s disease. Evotec is built on integrated drug discovery know how of more than years and is a leading player in the drug discovery field. The Company s headquarters are located in Hamburg, Germany. Additional major operations are based in Abingdon, UK, G ttingen, Munich, Germany, Thane, India and San Francisco, USA. Evotec has more than employees worldwide.
Quote | Evotec Ag Ord (OTCMKTS:EVOTF)
Last: | $8.98 |
---|---|
Change Percent: | 0.0% |
Open: | $8.98 |
Close: | $8.98 |
High: | $8.98 |
Low: | $8.98 |
Volume: | 182 |
Last Trade Date Time: | 06/14/2024 03:00:00 am |
News | Evotec Ag Ord (OTCMKTS:EVOTF)
Just - Evotec Biologics will deliver an ultra-rapid, cost-efficient biotherapeutics manufacturing platform solution for the DOD's Manufacturing Optimization Program Manufacturing solution includes seamless integration of accelerated mAb drug development into the overall Manufacturing Optimiz...
Key scientific achievement advances the joint pipeline in the strategic neuroscience partnership with Bristol Myers Squibb and earns a payment of US$ 20 m to Evotec to progress further research HAMBURG, GERMANY / ACCESSWIRE / June 12, 2024 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/T...
Message Board Posts | Evotec Ag Ord (OTCMKTS:EVOTF)
Subject | By | Source | When |
---|---|---|---|
chartguy89: EVOTF 5.98 Stock Charts $EVOTF 1 Month Chart | chartguy89 | investorshangout | 03/07/2014 8:52:52 AM |
chartguy89: EVOTF Stock Charts Last: +0.08 Wednesday, February 26, 2014 at 1:23:53 AM $EVOTF | chartguy89 | investorshangout | 02/26/2014 6:24:04 AM |
News, Short Squeeze, Breakout and More Instantly...
Just - Evotec Biologics will deliver an ultra-rapid, cost-efficient biotherapeutics manufacturing platform solution for the DOD's Manufacturing Optimization Program Manufacturing solution includes seamless integration of accelerated mAb drug development into the overall Manufacturing Optimiz...
Key scientific achievement advances the joint pipeline in the strategic neuroscience partnership with Bristol Myers Squibb and earns a payment of US$ 20 m to Evotec to progress further research HAMBURG, GERMANY / ACCESSWIRE / June 12, 2024 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/T...
Most agenda items adopted with great majority Annual General Meeting 2024 elects Dr Duncan McHale and Wesley Wheeler to the Supervisory Board, replacing Dr Elaine Sullivan and Dr Mario Polywka HAMBURG, GERMANY / ACCESSWIRE / June 10, 2024 / Evotec SE (Frankfurt Stock Exchange:EVT)(MDA...